Follow
Swetha Thiyagarajan
Swetha Thiyagarajan
BioMarin Pharmaceutical Inc
Verified email at ndsu.edu
Title
Cited by
Cited by
Year
RAGE up-regulation differently affects cell proliferation and migration in pancreatic cancer cells
P Swami, S Thiyagarajan, A Vidger, VSK Indurthi, SW Vetter, E Leclerc
International Journal of Molecular Sciences 21 (20), 7723, 2020
252020
Inhibition of the receptor for advanced glycation End products enhances the cytotoxic effect of gemcitabine in murine pancreatic tumors
P Swami, KA O’connell, S Thiyagarajan, A Crawford, P Patil, ...
Biomolecules 11 (4), 526, 2021
72021
Activation of the receptor for glycation end products (RAGE) by its ligands in pancreatic cancer cells
S Kadasah, S Thiyagarajan, S Vetter, E Leclerc
The FASEB Journal 33 (1_supplement), 476.11-476.11, 2019
22019
The cytoplasmic domain of RAGE (Receptor for Advanced Glycation Endproduct) is selfsufficient to contribute cell adhesion in the presence of extracellular matrix
S Thiyagarajan, E Leclerc, S Vetter
The FASEB Journal 33 (1_supplement), 680.5-680.5, 2019
12019
S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
A Mandarino, S Thiyagarajan, ACF Martins, RS Gomes, SW Vetter, ...
Biomolecules 13 (8), 1175, 2023
2023
Understanding the Role of RAGE in Cell Adhesion
S Thiyagarajan
North Dakota State University, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–6